CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG)

CUSIP: 15117P102

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM NEW
Total 13F shares
453,738
Share change
-94,633
Total reported value
$5,125,214
Price per share
$11.29
Number of holders
15
Value change
-$1,039,031
Number of buys
5
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 15117P102?
CUSIP 15117P102 identifies CBMG - CELLULAR BIOMEDICINE GROUP I - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) as of Q4 2017

As of 31 Dec 2017, CELLULAR BIOMEDICINE GROUP I - COM NEW (CBMG) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 453,738 shares. The largest 10 holders included MILLENNIUM MANAGEMENT LLC, BlackRock Inc., Vanguard Group Inc, BRIDGEWAY CAPITAL MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Zurcher Kantonalbank (Zurich Cantonalbank), SIMPLEX TRADING, LLC, and BARCLAYS PLC. This page lists 15 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.